Neuroscientific Biopharmaceuticals

Feb 3, 2023

NeuroScientific Biopharmaceuticals Secures $3.7m tax incentive refund NeuroScientific Biopharmaceuticals ( NSB ) pockets a $3.7 million tax refund from the Australian Federal Government. The company received the government incentive payment for research and development undertaken during the 2021/2022 financial year The government incentive program offers cash refunds for up to 43.5 per cent of eligible expenditure on research and development NSB says the refund will be reinvested into its preclinical and clinical research programs currently being undertaken to support the commercialisation of its lead drug candidate, EmtinB NeuroScientificBiopharmaceuticals is up 1.02 per cent and trading at 9.9 cents at 3:29 pm AEDT Tags: